Toll-like Receptor 4 Mediates Induction of the Bcl10-NFkappaB-interleukin-8 Inflammatory Pathway by Carrageenan in Human Intestinal Epithelial Cells
Overview
Authors
Affiliations
The sulfated polysaccharide carrageenan (CGN) induces activation of NFkappaB and interleukin 8 (IL-8) in human colonic epithelial cells through a pathway of innate immunity mediated by Bcl10 (B-cell CLL/lymphoma 10). In this report, we identify Toll-like receptor 4 (TLR4), a member of the family of innate immune receptors, as the surface membrane receptor for CGN in human colonic epithelial cells. Experiments with fluorescence-tagged CGN demonstrated a marked reduction in binding of CGN to human intestinal epithelial cells and to RAW 264.7 mouse macrophages, following exposure to TLR4 blocking antibody (HTA-125). Binding of CGN to 10ScNCr/23 mouse macrophages, which are deficient in the genetic locus for TLR4, was absent. Additional experiments with TLR4 blocking antibody and TLR4 small interfering RNAs showed 80% reductions in CGN-induced increases in Bcl10 and IL-8. Transfection with dominant-negative MyD88 plasmid demonstrated MyD88 dependence of the CGN-TLR4-triggered increases in Bcl10 and IL-8. Therefore, these results indicate that CGN-induced inflammation in human colonocytes proceeds through a pathway of innate immunity, perhaps related to the unusual alpha-1,3-galactosidic linkage characteristic of CGN, and suggest how dietary CGN intake may contribute to human intestinal inflammation. Because CGN is a commonly used food additive in the Western diet, clarification of its effects and mechanisms of action are vital to issues of food safety.
Intestinal permeability, food antigens and the microbiome: a multifaceted perspective.
Valitutti F, Mennini M, Monacelli G, Fagiolari G, Piccirillo M, Di Nardo G Front Allergy. 2025; 5():1505834.
PMID: 39850945 PMC: 11754301. DOI: 10.3389/falgy.2024.1505834.
Albaladejo-Riad N, El Qendouci M, Cuesta A, Esteban M Sci Rep. 2024; 14(1):31404.
PMID: 39732927 PMC: 11682419. DOI: 10.1038/s41598-024-83033-y.
Carrageenan and insulin resistance in humans: a randomised double-blind cross-over trial.
Wagner R, Buettner J, Heni M, Fritsche L, Kullmann S, Wagmuller M BMC Med. 2024; 22(1):558.
PMID: 39593091 PMC: 11590543. DOI: 10.1186/s12916-024-03771-8.
Justil-Guerrero H, Arroyo-Acevedo J, Rojas-Armas J, Garcia-Bustamante C, Palomino-Pacheco M, Almonacid-Roman R Molecules. 2024; 29(20).
PMID: 39459332 PMC: 11510094. DOI: 10.3390/molecules29204964.
Kumari B, Tiwari A, Meena S, Ahirwar D Cancers (Basel). 2024; 16(18).
PMID: 39335106 PMC: 11429849. DOI: 10.3390/cancers16183134.